Sign inJoin waitlistJoin the waitlist

YS

Yungpo Su

Physician · Oncology Hematology West PC

Credentials: · · · ·

History

Oncology Hematology West PC
Present

Medical Oncology
2001–2003
Internal Medicine
1998–2001
New York University Grossman School of Medicine
1994–1998

Research

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine · 2022 · 277 citations
Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new…
Journal of Clinical Oncology · 2006 · 249 citations
Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications
Journal of Clinical Oncology · 2004 · First of 10 authors · 214 citations

MF
Matthew Fury
5 papers
David Pfister
4 papers
Ashok Shaha
3 papers
IL
Israel Lowy
3 papers
NK
Nikhil Khushalani
3 papers
Vishal Patel
3 papers
Andrew Coughlin
2 papers
DK
Dennis Kraus
2 papers
Elias Jabbour
2 papers
Emily Ruiz
2 papers
EL
Evan Lipson
2 papers
Hagop Kantarjian
2 papers

Clinical trials

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Site PI · Not yet recruiting · Phase 3
Corbus Pharmaceuticals Inc.
2026–2029
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2033
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Site PI · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2024–2030
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029